The Epidemiology of Oral HPV Infection among a Multinational Sample of Healthy Men

Background: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. Methods: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the U...

Full description

Saved in:
Bibliographic Details
Published inCancer epidemiology, biomarkers & prevention Vol. 20; no. 1; pp. 172 - 182
Main Authors Kreimer, Aimee R., Villa, Alessandro, Nyitray, Alan G., Abrahamsen, Martha, Papenfuss, Mary, Smith, Danelle, Hildesheim, Allan, Villa, Luisa L., Lazcano-Ponce, Eduardo, Giuliano, Anna R.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 01.01.2011
Subjects
Online AccessGet full text
ISSN1055-9965
1538-7755
1538-7755
DOI10.1158/1055-9965.EPI-10-0682

Cover

Abstract Background: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. Methods: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array. Results: Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%–5.0%) β-globin–positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%–2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%–1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (Ptrend = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4–4.4). Oral sexual behaviors were not associated with oral HPV infection. Conclusions: Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use. Impact: Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. Cancer Epidemiol Biomarkers Prev; 20(1); 172–82. ©2011 AACR.
AbstractList Background: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. Methods: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array. Results: Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%–5.0%) β-globin–positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%–2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%–1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (Ptrend = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4–4.4). Oral sexual behaviors were not associated with oral HPV infection. Conclusions: Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use. Impact: Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. Cancer Epidemiol Biomarkers Prev; 20(1); 172–82. ©2011 AACR.
BACKGROUND: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. METHODS: Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array. RESULTS: Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) beta -globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (Ptrend = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection. CONCLUSIONS: Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use. IMPACT: Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. similar to 40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites. Cancer Epidemiol Biomarkers Prev; 20(1); 172-82. [copy ]2011 AACR.
Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array. Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) β-globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (P(trend) = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection. Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use. Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites.
Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.BACKGROUNDOral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.Oral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array.METHODSOral rinse/gargle specimens and questionnaire data were collected from 1,688 healthy men aged 18 to 74 (median = 31 years), from the United States, Mexico, and Brazil. HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 59, and noncarcinogenic HPV types were detected using Roche Linear Array.Oral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) β-globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (P(trend) = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection.RESULTSOral HPV DNA was detected in 67 of 1,680 (4.0%, 95% CI = 3.1%-5.0%) β-globin-positive specimens; carcinogenic HPVs were detected in 1.3% (95% CI = 0.8%-2.0%; n = 22) and HPV16 was the most commonly detected carcinogenic HPV type (0.6%, 95% CI = 0.2%-1.1%; n = 10). The prevalence of oral HPV infection was similar by country except for HPV55, which had notably higher prevalence in Mexico (3.0%) than Brazil (0%) or the United States (0.2%). Oral HPV prevalence nonsignificantly increased over increasing age categories (P(trend) = 0.096). The strongest predictor of oral HPV was current tobacco use, which increased the odds 2.5-fold (95% CI = 1.4-4.4). Oral sexual behaviors were not associated with oral HPV infection.Oral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use.CONCLUSIONSOral HPV16 infection was rare in healthy men, especially at younger ages, and was positively associated with current tobacco use.Oral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites.IMPACTOral HPV appears to be about 10-fold less prevalent than infection at genital sites in men (4% vs. ∼40%, respectively). It remains unclear whether this reflects reduced exposure or if the oral region is more resistant to HPV infection compared with anogenital sites.
Author Smith, Danelle
Papenfuss, Mary
Kreimer, Aimee R.
Villa, Alessandro
Hildesheim, Allan
Giuliano, Anna R.
Abrahamsen, Martha
Villa, Luisa L.
Nyitray, Alan G.
Lazcano-Ponce, Eduardo
AuthorAffiliation 1 National Cancer Institute, NIH, Bethesda, Maryland
4 Instituto Nacional de Salud Pública, Cuernavaca, México
2 H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3 Ludwig Institute for Cancer Research, São Paulo, Brazil
AuthorAffiliation_xml – name: 1 National Cancer Institute, NIH, Bethesda, Maryland
– name: 2 H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
– name: 4 Instituto Nacional de Salud Pública, Cuernavaca, México
– name: 3 Ludwig Institute for Cancer Research, São Paulo, Brazil
Author_xml – sequence: 1
  givenname: Aimee R.
  surname: Kreimer
  fullname: Kreimer, Aimee R.
– sequence: 2
  givenname: Alessandro
  surname: Villa
  fullname: Villa, Alessandro
– sequence: 3
  givenname: Alan G.
  surname: Nyitray
  fullname: Nyitray, Alan G.
– sequence: 4
  givenname: Martha
  surname: Abrahamsen
  fullname: Abrahamsen, Martha
– sequence: 5
  givenname: Mary
  surname: Papenfuss
  fullname: Papenfuss, Mary
– sequence: 6
  givenname: Danelle
  surname: Smith
  fullname: Smith, Danelle
– sequence: 7
  givenname: Allan
  surname: Hildesheim
  fullname: Hildesheim, Allan
– sequence: 8
  givenname: Luisa L.
  surname: Villa
  fullname: Villa, Luisa L.
– sequence: 9
  givenname: Eduardo
  surname: Lazcano-Ponce
  fullname: Lazcano-Ponce, Eduardo
– sequence: 10
  givenname: Anna R.
  surname: Giuliano
  fullname: Giuliano, Anna R.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23757458$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21148755$$D View this record in MEDLINE/PubMed
BookMark eNqFkltr3DAQhUVJaZJtf0KLXkqenOpiWRaFQgnb7EJCQpvkVcjyeFdFlraWN7D_vnKySS8veZIYfedwNDPH6CDEAAi9p-SUUlF_okSIQqlKnM6vlwUlBalq9godUcHrQkohDvL9iTlExyn9JIRIJcQbdMgoLevMHKHvN2vA841roXfRx9UOxw5fDcbjxfUdXoYO7OhiwKaPYYUNvtz60QUz1TLzw_QbD5NkAcaP6x2-hPAWve6MT_Buf87Q7bf5zdmiuLg6X559vShsjjgWsgFFWKugIrWtKK04pw1thGJEVcxIwYWsiDK2VZ0VDeVU8o6QWkoJnKmWz9CXR9_NtumhtRDGnFtvBtebYaejcfrfl-DWehXvNSdMUl5ng5O9wRB_bSGNunfJgvcmQNwmrUhZViXl6kWyZiz_hWTXGfrwd6jnNE8dz8DHPWCSNb4bTLAu_eG4FLIUUzjxyNkhpjRA94xQoqcN0NN09TRdnTdgqk4bkHWf_9NZNz7MK_fA-RfUvwGt_LRR
CODEN CEBPE4
CitedBy_id crossref_primary_10_1016_j_oraloncology_2013_06_002
crossref_primary_10_1684_bdc_2014_1957
crossref_primary_10_1097_OLQ_0b013e31824f1c65
crossref_primary_10_1186_1471_2407_11_473
crossref_primary_10_1016_j_oraloncology_2013_06_007
crossref_primary_10_1002_osi2_1022
crossref_primary_10_1080_23744235_2017_1300319
crossref_primary_10_1016_j_ijid_2018_02_003
crossref_primary_10_1016_S1773_035X_11_71056_5
crossref_primary_10_1515_ii_2017_0113
crossref_primary_10_1002_jmv_27893
crossref_primary_10_5935_1808_8694_20130107
crossref_primary_10_1186_1472_6831_11_28
crossref_primary_10_1002_ijc_33442
crossref_primary_10_1016_j_oraloncology_2018_04_005
crossref_primary_10_1007_s10552_017_0966_z
crossref_primary_10_1038_srep15637
crossref_primary_10_15446_revfacmed_v64n1_53736
crossref_primary_10_1002_lary_25767
crossref_primary_10_1002_ijc_33732
crossref_primary_10_3390_pharmaceutics11070302
crossref_primary_10_1111_jop_12291
crossref_primary_10_1002_cncr_29111
crossref_primary_10_1200_JCO_2014_55_1341
crossref_primary_10_1158_1940_6207_CAPR_13_0081
crossref_primary_10_1016_j_eururo_2012_06_045
crossref_primary_10_1002_ijc_29082
crossref_primary_10_1002_lio2_316
crossref_primary_10_1097_QAD_0b013e328362395c
crossref_primary_10_1007_s12105_012_0377_0
crossref_primary_10_3390_jcm11071935
crossref_primary_10_1002_lary_26175
crossref_primary_10_1016_j_oooo_2015_04_004
crossref_primary_10_1016_j_vaccine_2019_08_058
crossref_primary_10_3390_ijerph19127213
crossref_primary_10_3390_pathogens10111411
crossref_primary_10_1590_1414_431X20132703
crossref_primary_10_1016_j_pvr_2018_03_003
crossref_primary_10_1016_j_otc_2012_04_003
crossref_primary_10_1128_JCM_05933_11
crossref_primary_10_1071_SH16155
crossref_primary_10_1002_jmv_24555
crossref_primary_10_1093_infdis_jix245
crossref_primary_10_1158_1055_9965_EPI_14_0386
crossref_primary_10_1158_1940_6207_CAPR_11_0379
crossref_primary_10_1097_OLQ_0b013e31827e87bd
crossref_primary_10_1016_j_meegid_2020_104283
crossref_primary_10_14219_jada_archive_2012_0194
crossref_primary_10_1186_1471_2334_14_43
crossref_primary_10_1016_j_bjid_2013_07_013
crossref_primary_10_1158_1940_6207_CAPR_23_0317
crossref_primary_10_1177_1559827615569707
crossref_primary_10_35509_01239015_30
crossref_primary_10_1016_j_vaccine_2021_07_069
crossref_primary_10_1097_PAT_0000000000000068
crossref_primary_10_1002_ijc_28201
crossref_primary_10_1007_s10096_013_1938_1
crossref_primary_10_1371_journal_pone_0143698
crossref_primary_10_1093_aje_kwu247
crossref_primary_10_1002_cam4_5686
crossref_primary_10_1097_CCO_0b013e32836242b4
crossref_primary_10_1016_j_virol_2017_07_006
crossref_primary_10_1016_j_virol_2016_04_031
crossref_primary_10_1097_OLQ_0000000000000264
crossref_primary_10_1111_j_1601_0825_2011_01892_x
crossref_primary_10_1002_jmv_26356
crossref_primary_10_1038_s41379_022_01024_8
crossref_primary_10_1371_journal_pone_0157976
crossref_primary_10_1016_j_epidem_2017_08_001
crossref_primary_10_1128_jcm_01403_22
crossref_primary_10_1016_j_oooo_2013_06_019
crossref_primary_10_1371_journal_pone_0091761
crossref_primary_10_1002_dc_22837
crossref_primary_10_1002_ijc_32713
crossref_primary_10_1016_j_jim_2013_10_005
crossref_primary_10_1099_jgv_0_000727
crossref_primary_10_1158_1940_6207_CAPR_14_0296
crossref_primary_10_1016_j_otoeng_2016_04_014
crossref_primary_10_1097_01_OLQ_0000430798_61475_08
crossref_primary_10_1016_j_otorri_2016_04_003
crossref_primary_10_3390_cancers6031705
crossref_primary_10_1158_1055_9965_EPI_14_0084
crossref_primary_10_1002_cncr_30312
crossref_primary_10_1111_jop_13474
crossref_primary_10_1097_OLQ_0000000000001802
crossref_primary_10_1097_OLQ_0b013e318269d098
crossref_primary_10_1111_odi_12365
crossref_primary_10_1007_s10096_014_2061_7
crossref_primary_10_1016_j_otpol_2014_05_004
crossref_primary_10_1080_21505594_2014_999570
crossref_primary_10_1111_1469_0691_12523
crossref_primary_10_1002_ijc_29827
crossref_primary_10_1097_OLQ_0000000000000159
crossref_primary_10_12998_wjcc_v2_i6_172
crossref_primary_10_1038_s41564_024_01824_5
crossref_primary_10_1371_journal_pone_0165847
crossref_primary_10_1016_j_oraloncology_2020_104669
crossref_primary_10_1158_1055_9965_EPI_11_0734
crossref_primary_10_1136_sextrans_2020_054428
crossref_primary_10_1111_jicd_12313
crossref_primary_10_1128_JCM_00286_14
crossref_primary_10_1016_j_oraloncology_2013_09_003
crossref_primary_10_1016_j_pvr_2015_06_007
crossref_primary_10_1016_j_vaccine_2019_03_034
crossref_primary_10_1016_j_cct_2021_106592
crossref_primary_10_1007_s13193_016_0559_4
crossref_primary_10_1186_1472_6831_12_43
crossref_primary_10_1097_OLQ_0000000000000563
crossref_primary_10_1002_jmv_26130
crossref_primary_10_3390_diagnostics11122180
crossref_primary_10_1016_j_oraloncology_2017_01_001
crossref_primary_10_1016_j_amjoto_2019_02_006
crossref_primary_10_1002_ijc_34517
crossref_primary_10_1007_s00784_019_03048_y
crossref_primary_10_1186_1472_6831_14_7
crossref_primary_10_1007_s12105_023_01597_z
crossref_primary_10_1080_23744235_2020_1811373
crossref_primary_10_1158_1055_9965_EPI_23_0626
crossref_primary_10_3390_cancers17030344
crossref_primary_10_1016_j_vaccine_2018_02_079
crossref_primary_10_1111_odi_13510
crossref_primary_10_5812_ijhrba_18053
crossref_primary_10_1002_ijc_32570
crossref_primary_10_1016_j_medcli_2023_04_032
crossref_primary_10_3390_cancers6031691
crossref_primary_10_1002_cncr_32152
crossref_primary_10_1016_S0140_6736_13_60809_0
crossref_primary_10_1016_j_canep_2011_12_007
crossref_primary_10_1111_ors_12152
crossref_primary_10_18632_oncotarget_27436
crossref_primary_10_1016_j_prp_2018_08_032
crossref_primary_10_1016_j_medcle_2023_04_033
crossref_primary_10_1016_j_oooo_2019_12_005
crossref_primary_10_1515_hsz_2017_0105
crossref_primary_10_1136_sextrans_2014_051955
crossref_primary_10_1016_j_vaccine_2012_05_070
crossref_primary_10_1007_s00106_012_2552_8
crossref_primary_10_1016_j_hoc_2024_04_001
crossref_primary_10_1093_infdis_jit369
crossref_primary_10_1093_cid_ciaa1701
crossref_primary_10_1111_odi_12550
crossref_primary_10_1007_s00106_013_2676_5
crossref_primary_10_5937_bjdm2301038A
crossref_primary_10_1016_j_pvr_2020_100199
Cites_doi 10.1097/00007435-199904001-00002
10.1097/OLQ.0b013e3181c94a3b
10.1086/514052
10.1158/1055-9965.EPI-05-0460
10.1128/JCM.36.10.3020-3027.1998
10.1056/NEJMoa065497
10.1086/597755
10.1158/1055-9965.EPI-04-0551
10.1158/1055-9965.EPI-09-0983
10.1016/S1473-3099(07)70158-5
10.1158/1055-9965.EPI-05-0983
10.1093/oxfordjournals.jncimonographs.a003477
10.1158/1055-9965.EPI-08-0151
10.1016/j.virol.2005.04.002
10.1093/aje/kwp225
10.1093/jnci/94.18.1406
10.1086/381504
10.1002/cncr.22963
10.1016/S1470-2045(09)70096-8
10.1111/j.1600-0714.2007.00556.x
10.1002/ijc.21731
10.1097/INF.0b013e318124a4ae
10.1002/ijc.24097
10.1128/JCM.38.1.357-361.2000
10.1093/jnci/djn025
10.1023/A:1020668232219
10.1128/JCM.43.11.5526-5535.2005
ContentType Journal Article
Copyright 2015 INIST-CNRS
2011 AACR.
Copyright © 2010 American Association for Cancer Research 2010
Copyright_xml – notice: 2015 INIST-CNRS
– notice: 2011 AACR.
– notice: Copyright © 2010 American Association for Cancer Research 2010
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7U1
7U9
C1K
H94
5PM
DOI 10.1158/1055-9965.EPI-10-0682
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Risk Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Risk Abstracts
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList CrossRef
Risk Abstracts
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7755
EndPage 182
ExternalDocumentID PMC3027138
21148755
23757458
10_1158_1055_9965_EPI_10_0682
Genre Journal Article
Research Support, N.I.H., Intramural
Research Support, N.I.H., Extramural
GeographicLocations Brazil
United States
Mexico
USA
GeographicLocations_xml – name: Mexico
– name: United States
– name: Brazil
– name: USA
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01CA098803
– fundername: NCI NIH HHS
  grantid: R01 CA098803
– fundername: Intramural NIH HHS
  grantid: ZIA CP010209
– fundername: NCI NIH HHS
  grantid: P30 CA076292
GroupedDBID ---
18M
29B
2FS
2WC
34G
39C
53G
5GY
5VS
6J9
AAFWJ
AAYXX
ABOCM
ACPRK
ADBBV
ADCOW
AENEX
AFHIN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BR6
BTFSW
C1A
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
H13
IH2
KQ8
L7B
OK1
P2P
PQQKQ
QTD
RCR
RHI
SJN
UDS
W8F
WOQ
.55
3O-
AI.
H~9
IQODW
VH1
WHG
X7M
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7U1
7U9
C1K
H94
5PM
ID FETCH-LOGICAL-c538t-7be902d9e608c6116331b1b5920962a75357609acd9fc5b13173f008777e329d3
ISSN 1055-9965
1538-7755
IngestDate Thu Aug 21 14:31:15 EDT 2025
Fri Jul 11 10:55:19 EDT 2025
Thu Jul 10 18:23:14 EDT 2025
Mon Jul 21 06:06:50 EDT 2025
Mon Jul 21 09:13:11 EDT 2025
Tue Jul 01 04:31:21 EDT 2025
Thu Apr 24 23:00:25 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Human
Healthy subject
Oral administration
Male
Papovaviridae
Epidemiology
Papillomavirus
Virus
Infection
Human papillomavirus
Cancerology
Adult
Public health
Language English
License CC BY 4.0
2011 AACR.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c538t-7be902d9e608c6116331b1b5920962a75357609acd9fc5b13173f008777e329d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://aacrjournals.org/cebp/article-pdf/20/1/172/2272672/172.pdf
PMID 21148755
PQID 822902071
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3027138
proquest_miscellaneous_904464139
proquest_miscellaneous_822902071
pubmed_primary_21148755
pascalfrancis_primary_23757458
crossref_primary_10_1158_1055_9965_EPI_10_0682
crossref_citationtrail_10_1158_1055_9965_EPI_10_0682
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-01-01
PublicationDateYYYYMMDD 2011-01-01
PublicationDate_xml – month: 01
  year: 2011
  text: 2011-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
– name: United States
PublicationTitle Cancer epidemiology, biomarkers & prevention
PublicationTitleAlternate Cancer Epidemiol Biomarkers Prev
PublicationYear 2011
Publisher American Association for Cancer Research
Publisher_xml – name: American Association for Cancer Research
References Kreimer (2022060919565960600_bib5) 2010; 37
D'Souza (2022060919565960600_bib4) 2007; 356
Castellsague (2022060919565960600_bib18) 1997; 176
Montaldo (2022060919565960600_bib7) 2007; 36
Bouvard (2022060919565960600_bib2) 2009; 10
Smith (2022060919565960600_bib8) 2007; 26
Nyitray (2022060919565960600_bib14) 2010
Hernandez (2022060919565960600_bib15) 2005; 14
Giuliano (2022060919565960600_bib9) 2008; 17
Gravitt (2022060919565960600_bib11) 1998; 36
Proia (2022060919565960600_bib21) 2006; 15
Vaccarella (2022060919565960600_bib28) 2010; 19
De Sanjose (2022060919565960600_bib13) 2007; 7
Castle (2022060919565960600_bib23) 2002; 94
Franceschi (2022060919565960600_bib17) 2002
Schiffman (2022060919565960600_bib26) 2005; 337
Cates (2022060919565960600_bib29) 1999; 26
D'Souza (2022060919565960600_bib10) 2005; 43
D'Souza (2022060919565960600_bib20) 2009; 199
Giuliano (2022060919565960600_bib24) 2002; 13
Sturgis (2022060919565960600_bib30) 2007; 110
Gravitt (2022060919565960600_bib12) 2000; 38
Parkin (2022060919565960600_bib1) 2006; 118
Nyitray (2022060919565960600_bib25) 2009; 170
Kreimer (2022060919565960600_bib6) 2004; 189
Giuliano (2022060919565960600_bib16) 2009; 124
Chaturvedi (2022060919565960600_bib27) 2010
Gillison (2022060919565960600_bib19) 2008; 100
Castellsague (2022060919565960600_bib22) 2003
Kreimer (2022060919565960600_bib3) 2005; 14
References_xml – volume: 26
  start-page: S2
  year: 1999
  ident: 2022060919565960600_bib29
  article-title: Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel
  publication-title: Sex Transm Dis
  doi: 10.1097/00007435-199904001-00002
– volume: 37
  start-page: 386
  year: 2010
  ident: 2022060919565960600_bib5
  article-title: Oral human papillomavirus in healthy individuals: a systematic review of the literature
  publication-title: Sex Transm Dis
  doi: 10.1097/OLQ.0b013e3181c94a3b
– volume: 176
  start-page: 353
  year: 1997
  ident: 2022060919565960600_bib18
  article-title: Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia
  publication-title: J Infect Dis
  doi: 10.1086/514052
– volume: 14
  start-page: 2550
  year: 2005
  ident: 2022060919565960600_bib15
  article-title: Anal human papillomavirus infection in women and its relationship with cervical infection
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-05-0460
– year: 2010
  ident: 2022060919565960600_bib27
  article-title: Oral and anal HPV infection among HIV-infected men and women
– volume: 36
  start-page: 3020
  year: 1998
  ident: 2022060919565960600_bib11
  article-title: Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.36.10.3020-3027.1998
– volume: 356
  start-page: 1944
  year: 2007
  ident: 2022060919565960600_bib4
  article-title: Case-control study of human papillomavirus and oropharyngeal cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa065497
– start-page: 1498
  volume-title: J Infect Dis
  year: 2010
  ident: 2022060919565960600_bib14
  article-title: Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study
– volume: 199
  start-page: 1263
  year: 2009
  ident: 2022060919565960600_bib20
  article-title: Oral sexual behaviors associated with prevalent oral human papillomavirus infection
  publication-title: J Infect Dis
  doi: 10.1086/597755
– start-page: 705
  volume-title: Br J Cancer
  year: 2002
  ident: 2022060919565960600_bib17
  article-title: Prevalence and determinants of human papillomavirus genital infection in men
– volume: 14
  start-page: 467
  year: 2005
  ident: 2022060919565960600_bib3
  article-title: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-04-0551
– volume: 19
  start-page: 503
  year: 2010
  ident: 2022060919565960600_bib28
  article-title: Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-09-0983
– volume: 7
  start-page: 453
  year: 2007
  ident: 2022060919565960600_bib13
  article-title: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(07)70158-5
– volume: 15
  start-page: 1061
  year: 2006
  ident: 2022060919565960600_bib21
  article-title: Smoking and smokeless tobacco-associated human buccal cell mutations and their association with oral cancer—a review
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-05-0983
– start-page: 20
  year: 2003
  ident: 2022060919565960600_bib22
  article-title: Cofactors in human papillomavirus carcinogenesis–role of parity, oral contraceptives, and tobacco smoking
  publication-title: J Natl Cancer Inst Monogr
  doi: 10.1093/oxfordjournals.jncimonographs.a003477
– volume: 17
  start-page: 2036
  year: 2008
  ident: 2022060919565960600_bib9
  article-title: The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-08-0151
– volume: 337
  start-page: 76
  year: 2005
  ident: 2022060919565960600_bib26
  article-title: The carcinogenicity of human papillomavirus types reflects viral evolution
  publication-title: Virology
  doi: 10.1016/j.virol.2005.04.002
– volume: 170
  start-page: 965
  year: 2009
  ident: 2022060919565960600_bib25
  article-title: Test-retest reliability of a sexual behavior interview for men residing in Brazil, Mexico, and the United States: the HPV in Men (HIM) Study
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwp225
– volume: 94
  start-page: 1406
  year: 2002
  ident: 2022060919565960600_bib23
  article-title: A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/94.18.1406
– volume: 189
  start-page: 686
  year: 2004
  ident: 2022060919565960600_bib6
  article-title: Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus
  publication-title: J Infect Dis
  doi: 10.1086/381504
– volume: 110
  start-page: 1429
  year: 2007
  ident: 2022060919565960600_bib30
  article-title: Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?
  publication-title: Cancer
  doi: 10.1002/cncr.22963
– volume: 10
  start-page: 321
  year: 2009
  ident: 2022060919565960600_bib2
  article-title: A review of human carcinogens–Part B: biological agents
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(09)70096-8
– volume: 36
  start-page: 482
  year: 2007
  ident: 2022060919565960600_bib7
  article-title: Detection and genotyping of human papillomavirus DNA in samples from healthy Sardinian patients: a preliminary study
  publication-title: J Oral Pathol Med
  doi: 10.1111/j.1600-0714.2007.00556.x
– volume: 118
  start-page: 3030
  year: 2006
  ident: 2022060919565960600_bib1
  article-title: The global health burden of infection-associated cancers in the year 2002
  publication-title: Int J Cancer
  doi: 10.1002/ijc.21731
– volume: 26
  start-page: 836
  year: 2007
  ident: 2022060919565960600_bib8
  article-title: Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0b013e318124a4ae
– volume: 124
  start-page: 1251
  year: 2009
  ident: 2022060919565960600_bib16
  article-title: Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study
  publication-title: Int J Cancer
  doi: 10.1002/ijc.24097
– volume: 38
  start-page: 357
  year: 2000
  ident: 2022060919565960600_bib12
  article-title: Improved amplification of genital human papillomaviruses
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.38.1.357-361.2000
– volume: 100
  start-page: 407
  year: 2008
  ident: 2022060919565960600_bib19
  article-title: Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djn025
– volume: 13
  start-page: 839
  year: 2002
  ident: 2022060919565960600_bib24
  article-title: Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States)
  publication-title: Cancer Causes Control
  doi: 10.1023/A:1020668232219
– volume: 43
  start-page: 5526
  year: 2005
  ident: 2022060919565960600_bib10
  article-title: Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR
  publication-title: J Clin Microbiol
  doi: 10.1128/JCM.43.11.5526-5535.2005
SSID ssj0007955
Score 2.425782
Snippet Background: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men....
Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men. Oral...
Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men.BACKGROUNDOral...
BACKGROUND: Oral human papillomavirus type-16 (HPV16) infection is a risk factor for oropharyngeal cancer. We examined oral HPV infection among healthy men....
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 172
SubjectTerms Adolescent
Adult
Age
Aged
Anogenital
Bioindicators
Biological and medical sciences
biomarkers
Brazil - epidemiology
Cancer
Carcinogenicity
Cohort Studies
Data processing
DNA
Epidemiology
Human papillomavirus
Human papillomavirus 16
Human papillomavirus 16 - isolation & purification
Humans
Infection
Inventories
Male
males
Medical sciences
Mexico - epidemiology
Middle Aged
Mouth - virology
Mouth Diseases - epidemiology
Mouth Diseases - virology
oropharyngeal cancer
Oropharyngeal Neoplasms - epidemiology
Oropharyngeal Neoplasms - virology
Papillomavirus Infections - epidemiology
Papillomavirus Infections - virology
Prevalence
Risk Factors
Sexual behavior
Smoking - epidemiology
Tobacco
Tumors
United States - epidemiology
Young Adult
Title The Epidemiology of Oral HPV Infection among a Multinational Sample of Healthy Men
URI https://www.ncbi.nlm.nih.gov/pubmed/21148755
https://www.proquest.com/docview/822902071
https://www.proquest.com/docview/904464139
https://pubmed.ncbi.nlm.nih.gov/PMC3027138
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1538-7755
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0007955
  issn: 1055-9965
  databaseCode: KQ8
  dateStart: 19911101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1538-7755
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0007955
  issn: 1055-9965
  databaseCode: DIK
  dateStart: 19910101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEkhHgu5bHygT2tsiRO7MTHamlVYF9Au-otchJHWwmlpY9D-Qf8a2ZsN03ZogUuUZT4IXk-2-PxzHyEvM1UwuIgKD2mtfAiwZSXlCz2RAGaHKgPkvkYjXx2LvrD6OOIj1qtnw2vpeUiO85_7Iwr-R-pwjeQK0bJ_oNk60bhA7yDfOEJEobnX8u4u6F4NZflFxhx37-8gplv3awqRyikjkywbW39-6owMbAx5BsfsBV6uDZ11RMExOxINzpAgWDAPvr0zOYGNlOXA6pxnT_TY8fJ0oEXvfFJvEKKIxdWM58rzJVQG6NX48VMrexPWHNqyq9OZmK5naEIsx5cq6apwgTsrU0VdnX1OffggMWbyy_zb8DMrqWB5fRx23JgOYpurvg8McYH1zKUHhtfO5GwzRa3vtY_v0h7w9PTdNAdDQ7D3vS7h_RjeE1_GL63-LhD7rJYCCTD-PR5k3g-loZAt-7HBYNB7-929r2l5jyYqjnMuNJSpew6y_zuktvQcQaPyEN3OKEdi7THpKWrJ-TemXO_eEq-AOBoE3B0UlIEHAXA0Rpw1ACOKroFOGoBh1Uc4CgA7hkZ9rqDk77nSDm8HPbGhRdnWvqskFr4SS4CUOfDIAsyDpNawkyH0y-cYH2p8kKWOc8C0E_D0jdpJ3XIZBE-J3vVpNIvCE0SGYdFmYdK6ygrlFSw5flKFDoSoGeKNonWY5jmLmM9Eqd8S83JlScpDn2KQ592Lz_gVxz6Njmuq01typbbKhxsCaiuxcKYxxFP2oSuJZbC6otXaqrSk-U8NXQJDNT0PxeR6DIBqqJsk30r4037aIyIOW-TeEv6dQHM_b79pxpfmxzw6G4QhMnL27t9Re5v5uJrsreYLfUbUKQX2YGB-C9Wx8ba
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Epidemiology+of+Oral+HPV+Infection+among+a+Multinational+Sample+of+Healthy+Men&rft.jtitle=Cancer+epidemiology%2C+biomarkers+%26+prevention&rft.au=Kreimer%2C+Aimee+R&rft.au=Villa%2C+Alessandro&rft.au=Nyitray%2C+Alan+G&rft.au=Abrahamsen%2C+Martha&rft.date=2011-01-01&rft.issn=1055-9965&rft.volume=20&rft.issue=1&rft.spage=172&rft.epage=182&rft_id=info:doi/10.1158%2F1055-9965.epi-10-0682&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1055-9965&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1055-9965&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1055-9965&client=summon